Vitamin Supplements Market Growth, Trends, Industry Statistics 2022-2030

The global Vitamin Supplements market size is expected to be worth around US$ 80.37 billion by 2030, according to a new report by Vision Research Reports.

The global Vitamin Supplements market size was valued at US$ 46.12 billion in 2020 and is anticipated to grow at a CAGR of 7.2% during forecast period 2021 to 2030.

Download Exclusive Sample of Report@ https://www.visionresearchreports.com/report/sample/38948

Report Coverage

Report Scope Details
Market Size US$ 80.37 Billion by 2030
Growth Rate CAGR of 7.2% From 2021 to 2030
Base Year 2021
Forecast Period 2021 to 2030
Segments Covered Type, Form, Distribution Channel
Regional Scope North America, Europe, Asia Pacific, Latin America, Middle East & Africa
Companies Mentioned Dabur India; NBTY Inc.; Ricola AG.; Mondelez International; Procter and Gamble; Nutraceutical International Company; BASF SE; The Himalaya Drug Company; Glanbia Nutritionals; Botanicalife International of America, Inc.; Blackmores Limited

Growth Factors

The market is expected to be driven by a rising number of health-conscious consumers and an increasing preference for vitamins in daily diet. The COVID-19 pandemic highlighted the need for vitamin consumption. The National Institute for Health and Care Excellence (NICE) of the U.K. stated that vitamin D is important for bone and muscle health and helps boost the body’s immune response to respiratory viruses. Additionally, it is recommended that adults (including pregnant women and breastfeeding women), children, and young people over the age of four years should contribute 10 micrograms of vitamin D daily to their diet.

The nutraceutical industry is an evolving and dynamic sector, which offers novel opportunities to collaborate scientific discovery with the growing consumer interest in health-enhancing foods. It tracks and monitors consumer trends and relationships with mass distributors, thus the products developed in this industry are a response to direct demand.

By Type Analysis

The multivitamin segment dominated the market and accounted for over 40.0% share of the global revenue in 2020. Multivitamin supplements comprise a combination of minerals and vitamins and at times other ingredients too.

The growing awareness regarding health and wellness has resulted in consumers preferring food products infused with vitamins that offer added health benefits and this is likely to shift the consumer attention from medical treatments to preventive care products.

The demand for multivitamin supplements is increasing across the globe as a complete pack of vitamins. Increased consumer awareness regarding the importance of adequate immunity amid the outbreak of the COVID-19 has increased the demand for immunity-boosting food and dietary supplements.

By Distribution Channel Analysis

The offline segment dominated the market and held a revenue share of over 75.0% in 2020. In the offline segment, the hypermarkets/supermarkets segment captured the largest revenue share of more than 40.0% in 2020.

The hypermarkets/supermarkets segment is gaining traction in the market. The well-maintained and arranged products, detailed customer sentimental analysis in order to understand consumer preferences pertaining to products and brands.

By Form Analysis

The tablets segment dominated the market and accounted for over 40.0% share of the global revenue in 2020as the tablet form of vitamins is widely consumed by adults across the world. Although the natural coating provides better dissolution, some other factors determine the absorption on the basis of efficacy and quality.

Tablet form is one of the easiest ways of vitamin supplement consumption. It can be consumed based on prescription and non-prescription as well. Tablets are easy to swallow and come in all types of vitamins. However, vitamin gummies are expected to witness higher growth in the forecast period.

Tablets are the most commonly used type of vitamin supplement owing to their cost-effectiveness. Manufacturers can pack the most amount in a given space in tablet form and tablets have a longer shelf life as compared to capsules.

By Regional Analysis

North America dominated the market and held a revenue share of over 30.0% in 2020. Among North Americans, there is an increase in obesity and lifestyle-related diseases due to their increasingly unhealthy diets, increased disposable income, and access to a variety of processed and ready-to-eat foods.

The consumption of products such as fortified, enhanced, enriched, and enhanced foods and nutritional supplements as part of a varied diet on a regular basis can have favorable influences on health.

Key Players

  • Glanbia Plc
  • Pfizer Inc.
  • Bayer AG
  • Amway Corp.
  • GlaxoSmithKline plc.
  • Good Health New Zealand
  • The Nature’s Bounty Co.
  • NOW Foods
  • Abbott
  • Herbalife Nutrition
  • Nature’s Sunshine Products, Inc.
  • NU SKIN
  • RBK Nutraceuticals Pty Ltd.
  • American Health, Inc.
  • Pharmavite

Market Segmentation

  • By Type
    • Multivitamin
    • Vitamin A
    • Vitamin B
    • Vitamin C
    • Vitamin D
    • Vitamin E
    • Vitamin K
  • By Form
    • Powder
    • Tablets
    • Capsules
    • Softgels
    • Gummies
    • Others
  • By Distribution Channel
    • Offline
      • Hypermarkets/Supermarkets
      • Specialty Stores
      • Others
    • Online
  • Regional
    • North America
      • U.S.
      • Canada
      • Mexico
    • Europe
      • U.K.
      • Germany
      • France
      • Italy
      • Russia
    • Asia Pacific
      • China
      • Japan
      • India
      • South Korea
      • Australia & New Zealand
    • Central & South America
      • Brazil
      • Argentina
    • Middle East & Africa
      • GCC
      • South Africa

Buy this Research Report study@ https://www.visionresearchreports.com/report/cart/38948

Reasons to Purchase this Report:

– Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
– Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
– Market value USD Million and volume Units Million data for each segment and sub-segment
– Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
– Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players

Table of Contents

Chapter 1.  Introduction

1.1.  Research Objective

1.2.  Scope of the Study

1.3.  Definition

Chapter 2.  Research Methodology

2.1.  Research Approach

2.2.  Data Sources

2.3.  Assumptions & Limitations

Chapter 3.  Executive Summary

3.1.  Market Snapshot

Chapter 4.  Market Variables and Scope

4.1.  Introduction

4.2.  Market Classification and Scope

4.3.  Industry Value Chain Analysis

4.3.1.    Raw Material Procurement Analysis

4.3.2.    Sales and Distribution Channel Analysis

4.3.3.    Downstream Buyer Analysis

Chapter 5.  Market Dynamics Analysis and Trends

5.1.  Market Dynamics

5.1.1.    Market Drivers

5.1.2.    Market Restraints

5.1.3.    Market Opportunities

5.2.  Porter’s Five Forces Analysis

5.2.1.    Bargaining power of suppliers

5.2.2.    Bargaining power of buyers

5.2.3.    Threat of substitute

5.2.4.    Threat of new entrants

5.2.5.    Degree of competition

Chapter 6.  Competitive Landscape

6.1.1.    Company Market Share/Positioning Analysis

6.1.2.    Key Strategies Adopted by Players

6.1.3.    Vendor Landscape

6.1.3.1.        List of Suppliers

6.1.3.2.        List of Buyers

Chapter 7.  Global Vitamin Supplements Market, By Type

7.1.  Vitamin Supplements Market, by Type, 2021-2030

7.1.1.    Multivitamin

7.1.1.1.        Market Revenue and Forecast (2017-2030)

7.1.2.    Vitamin A

7.1.2.1.        Market Revenue and Forecast (2017-2030)

7.1.3.    Vitamin B

7.1.3.1.        Market Revenue and Forecast (2017-2030)

7.1.4.    Vitamin C

7.1.4.1.        Market Revenue and Forecast (2017-2030)

7.1.5.    Vitamin D

7.1.5.1.        Market Revenue and Forecast (2017-2030)

7.1.6.    Vitamin E

7.1.6.1.        Market Revenue and Forecast (2017-2030)

7.1.7.    Vitamin K

7.1.7.1.        Market Revenue and Forecast (2017-2030)

Chapter 8.  Global Vitamin Supplements Market, By Form

8.1.  Vitamin Supplements Market, by Form, 2021-2030

8.1.1.    Powder

8.1.1.1.        Market Revenue and Forecast (2017-2030)

8.1.2.    Tablets

8.1.2.1.        Market Revenue and Forecast (2017-2030)

8.1.3.    Capsules

8.1.3.1.        Market Revenue and Forecast (2017-2030)

8.1.4.    Softgels

8.1.4.1.        Market Revenue and Forecast (2017-2030)

8.1.5.    Gummies

8.1.5.1.        Market Revenue and Forecast (2017-2030)

Chapter 9.  Global Vitamin Supplements Market, By Distribution Channel

9.1.  Vitamin Supplements Market, by Distribution Channel, 2021-2030

9.1.1.    Offline

9.1.1.1.        Market Revenue and Forecast (2017-2030)

9.1.2.    Online

9.1.2.1.        Market Revenue and Forecast (2017-2030)

Chapter 10.      Global Vitamin Supplements Market, Regional Estimates and Trend Forecast

10.1.        North America

10.1.1.  Market Revenue and Forecast, by Type (2017-2030)

10.1.2.  Market Revenue and Forecast, by Form (2017-2030)

10.1.3.  Market Revenue and Forecast, by Distribution Channel (2017-2030)

10.1.4.  U.S.

10.1.4.1.      Market Revenue and Forecast, by Type (2017-2030)

10.1.4.2.      Market Revenue and Forecast, by Form (2017-2030)

10.1.4.3.      Market Revenue and Forecast, by Distribution Channel (2017-2030)

10.1.5.  Rest of North America

10.1.5.1.      Market Revenue and Forecast, by Type (2017-2030)

10.1.5.2.      Market Revenue and Forecast, by Form (2017-2030)

10.1.5.3.      Market Revenue and Forecast, by Distribution Channel (2017-2030)

10.2.        Europe

10.2.1.  Market Revenue and Forecast, by Type (2017-2030)

10.2.2.  Market Revenue and Forecast, by Form (2017-2030)

10.2.3.  Market Revenue and Forecast, by Distribution Channel (2017-2030)

10.2.4.  UK

10.2.4.1.      Market Revenue and Forecast, by Type (2017-2030)

10.2.4.2.      Market Revenue and Forecast, by Form (2017-2030)

10.2.4.3.      Market Revenue and Forecast, by Distribution Channel (2017-2030)

10.2.5.  Germany

10.2.5.1.      Market Revenue and Forecast, by Type (2017-2030)

10.2.5.2.      Market Revenue and Forecast, by Form (2017-2030)

10.2.5.3.      Market Revenue and Forecast, by Distribution Channel (2017-2030)

10.2.6.  France

10.2.6.1.      Market Revenue and Forecast, by Type (2017-2030)

10.2.6.2.      Market Revenue and Forecast, by Form (2017-2030)

10.2.6.3.      Market Revenue and Forecast, by Distribution Channel (2017-2030)

10.2.7.  Rest of Europe

10.2.7.1.      Market Revenue and Forecast, by Type (2017-2030)

10.2.7.2.      Market Revenue and Forecast, by Form (2017-2030)

10.2.7.3.      Market Revenue and Forecast, by Distribution Channel (2017-2030)

10.3.        APAC

10.3.1.  Market Revenue and Forecast, by Type (2017-2030)

10.3.2.  Market Revenue and Forecast, by Form (2017-2030)

10.3.3.  Market Revenue and Forecast, by Distribution Channel (2017-2030)

10.3.4.  India

10.3.4.1.      Market Revenue and Forecast, by Type (2017-2030)

10.3.4.2.      Market Revenue and Forecast, by Form (2017-2030)

10.3.4.3.      Market Revenue and Forecast, by Distribution Channel (2017-2030)

10.3.5.  China

10.3.5.1.      Market Revenue and Forecast, by Type (2017-2030)

10.3.5.2.      Market Revenue and Forecast, by Form (2017-2030)

10.3.5.3.      Market Revenue and Forecast, by Distribution Channel (2017-2030)

10.3.6.  Japan

10.3.6.1.      Market Revenue and Forecast, by Type (2017-2030)

10.3.6.2.      Market Revenue and Forecast, by Form (2017-2030)

10.3.6.3.      Market Revenue and Forecast, by Distribution Channel (2017-2030)

10.3.7.  Rest of APAC

10.3.7.1.      Market Revenue and Forecast, by Type (2017-2030)

10.3.7.2.      Market Revenue and Forecast, by Form (2017-2030)

10.3.7.3.      Market Revenue and Forecast, by Distribution Channel (2017-2030)

10.4.        MEA

10.4.1.  Market Revenue and Forecast, by Type (2017-2030)

10.4.2.  Market Revenue and Forecast, by Form (2017-2030)

10.4.3.  Market Revenue and Forecast, by Distribution Channel (2017-2030)

10.4.4.  GCC

10.4.4.1.      Market Revenue and Forecast, by Type (2017-2030)

10.4.4.2.      Market Revenue and Forecast, by Form (2017-2030)

10.4.4.3.      Market Revenue and Forecast, by Distribution Channel (2017-2030)

10.4.5.  North Africa

10.4.5.1.      Market Revenue and Forecast, by Type (2017-2030)

10.4.5.2.      Market Revenue and Forecast, by Form (2017-2030)

10.4.5.3.      Market Revenue and Forecast, by Distribution Channel (2017-2030)

10.4.6.  South Africa

10.4.6.1.      Market Revenue and Forecast, by Type (2017-2030)

10.4.6.2.      Market Revenue and Forecast, by Form (2017-2030)

10.4.6.3.      Market Revenue and Forecast, by Distribution Channel (2017-2030)

10.4.7.  Rest of MEA

10.4.7.1.      Market Revenue and Forecast, by Type (2017-2030)

10.4.7.2.      Market Revenue and Forecast, by Form (2017-2030)

10.4.7.3.      Market Revenue and Forecast, by Distribution Channel (2017-2030)

10.5.        Latin America

10.5.1.  Market Revenue and Forecast, by Type (2017-2030)

10.5.2.  Market Revenue and Forecast, by Form (2017-2030)

10.5.3.  Market Revenue and Forecast, by Distribution Channel (2017-2030)

10.5.4.  Brazil

10.5.4.1.      Market Revenue and Forecast, by Type (2017-2030)

10.5.4.2.      Market Revenue and Forecast, by Form (2017-2030)

10.5.4.3.      Market Revenue and Forecast, by Distribution Channel (2017-2030)

10.5.5.  Rest of LATAM

10.5.5.1.      Market Revenue and Forecast, by Type (2017-2030)

10.5.5.2.      Market Revenue and Forecast, by Form (2017-2030)

10.5.5.3.      Market Revenue and Forecast, by Distribution Channel (2017-2030)

Chapter 11.  Company Profiles

11.1.              Glanbia Plc

11.1.1.  Company Overview

11.1.2.  Product Offerings

11.1.3.  Financial Performance

11.1.4.  Recent Initiatives

11.2.              Pfizer Inc.

11.2.1.  Company Overview

11.2.2.  Product Offerings

11.2.3.  Financial Performance

11.2.4.  Recent Initiatives

11.3.              Bayer AG

11.3.1.  Company Overview

11.3.2.  Product Offerings

11.3.3.  Financial Performance

11.3.4.  Recent Initiatives

11.4.              Amway Corp.

11.4.1.  Company Overview

11.4.2.  Product Offerings

11.4.3.  Financial Performance

11.4.4.  Recent Initiatives

11.5.              GlaxoSmithKline plc.

11.5.1.  Company Overview

11.5.2.  Product Offerings

11.5.3.  Financial Performance

11.5.4.  Recent Initiatives

11.6.              Good Health New Zealand

11.6.1.  Company Overview

11.6.2.  Product Offerings

11.6.3.  Financial Performance

11.6.4.  Recent Initiatives

11.7.              The Nature’s Bounty Co.

11.7.1.  Company Overview

11.7.2.  Product Offerings

11.7.3.  Financial Performance

11.7.4.  Recent Initiatives

11.8.              NOW Foods

11.8.1.  Company Overview

11.8.2.  Product Offerings

11.8.3.  Financial Performance

11.8.4.  Recent Initiatives

11.9.              Abbott

11.9.1.  Company Overview

11.9.2.  Product Offerings

11.9.3.  Financial Performance

11.9.4.  Recent Initiatives

11.10.           Herbalife Nutrition

11.10.1.               Company Overview

11.10.2.               Product Offerings

11.10.3.               Financial Performance

11.10.4.               Recent Initiatives

Chapter 12.  Research Methodology

12.1.              Primary Research

12.2.              Secondary Research

12.3.              Assumptions

Chapter 13.  Appendix

13.1.              About Us

13.2.              Glossary of Terms

Buy this Research Report study@ https://www.visionresearchreports.com/report/cart/38948

Contact Us:

Vision Research Reports

Call: +1 9197 992 333

Email: sales@visionresearchreports.com